These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1696270)

  • 1. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system.
    Sato Y; Tsuboi R; Lyons R; Moses H; Rifkin DB
    J Cell Biol; 1990 Aug; 111(2):757-63. PubMed ID: 1696270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.
    Sato Y; Rifkin DB
    J Cell Biol; 1989 Jul; 109(1):309-15. PubMed ID: 2526131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration.
    Kojima S; Harpel PC; Rifkin DB
    J Cell Biol; 1991 Jun; 113(6):1439-45. PubMed ID: 1828468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology.
    Powell RJ; Bhargava J; Basson MD; Sumpio BE
    Am J Physiol; 1998 Feb; 274(2):H642-9. PubMed ID: 9486269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cells modulate smooth muscle cell morphology by inhibition of transforming growth factor-beta 1 activation.
    Nackman GB; Bech FR; Fillinger MF; Wagner RJ; Cronenwett JL
    Surgery; 1996 Aug; 120(2):418-25; discussion 425-6. PubMed ID: 8751613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S; Nara K; Rifkin DB
    J Cell Biol; 1993 Apr; 121(2):439-48. PubMed ID: 8096847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S; Rifkin DB
    J Cell Physiol; 1993 May; 155(2):323-32. PubMed ID: 8482724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M; Podor TJ; Loskutoff DJ
    J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.
    Flaumenhaft R; Abe M; Mignatti P; Rifkin DB
    J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1.
    Kocher O; Madri JA
    In Vitro Cell Dev Biol; 1989 May; 25(5):424-34. PubMed ID: 2659578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells.
    Sato Y; Okada F; Abe M; Seguchi T; Kuwano M; Sato S; Furuya A; Hanai N; Tamaoki T
    J Cell Biol; 1993 Dec; 123(5):1249-54. PubMed ID: 8245129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation.
    Boudreau N; Clausell N; Boyle J; Rabinovitch M
    Lab Invest; 1992 Sep; 67(3):350-9. PubMed ID: 1405493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.
    Schultz-Cherry S; Murphy-Ullrich JE
    J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide inhibits activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S; Vernooy R; Moscatelli D; Amanuma H; Rifkin DB
    J Cell Physiol; 1995 Apr; 163(1):210-9. PubMed ID: 7896898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
    Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
    Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
    Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy inhibits transforming growth factor beta activity associated with vascular smooth muscle cell injury.
    Statius van Eps RG; LaMuraglia GM
    J Vasc Surg; 1997 Jun; 25(6):1044-52; discussion 1052-3. PubMed ID: 9201165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.
    Dennis PA; Rifkin DB
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):580-4. PubMed ID: 1846448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.